Portfolio: Investments

Affymax, Inc.
Exited via the public markets

Alinea Pharmaceuticals, Inc.
Diabetes and related metabolic disorders

Allozyne, Inc.
Next generation protein optimization

Alnara Pharmaceuticals
Focused on developing non systemic protein therapeutics for the treatment of metabolic diseases

Alsius Corporation
Acquired by Zoll Medical, Inc.

Archus Orthopedics, Inc.
Degenerative diseases of the lumbar spine